Diabetes and progression of coronary calcium under the influence of statin therapy - 21/08/11
, Dale Yu, MD a, Khurram Nasir, MD, MPH c, Rajnish Mehrotra, MD b, Lynn Chen a, Junichiro Takasu, MD, PhD a, Nisha Agrawal a, Sandy T. Liu a, Roger S. Blumenthal, MD cRésumé |
Background |
Coronary artery calcium (CAC) is a sensitive marker for the detection of coronary heart disease (CHD). Coronary artery calcification can be accurately quantified using electron beam tomography (EBT). We sought to evaluate the progression of atherosclerosis in asymptomatic persons with type 2 diabetes and measure the influence of statin therapy on CAC progression.
Methods |
We evaluated 163 asymptomatic patients with type 2 diabetes (120 men, 43 women). Patients were physician referred and underwent 2 consecutive EBT scans at least 1 year apart. Demographic data, risk factors for CHD, and medication use were collected. Patients with symptoms or known CHD were excluded.
Results |
The mean age was 65 ± 10 years. The mean CAC score at baseline was 651 ± 414. Only 9 (6%) of 163 of participants had scores of 0 at baseline. The time between scans averaged 27 ± 15 months. Patients not treated with statins demonstrated a median annual increase in CAC progression of 20% (4%-44%), whereas statin-treated patients demonstrated increase of 10% (4%-25%) (P = .0001). Hemoglobin A1c was weakly associated with CAC progression.
Conclusions |
Asymptomatic diabetic patients show a high prevalence of atherosclerosis based on high frequency of coronary calcification. Statin therapy induced a 50% reduction in the rate of CAC progression. As rapid CAC progression has been associated with coronary events, EBT may serve as a noninvasive method for following atherosclerosis and response to therapy.
Le texte complet de cet article est disponible en PDF.Plan
Vol 149 - N° 4
P. 695-700 - avril 2005 Retour au numéro
Article précédent
- Two-year clinical follow-up of 90Sr/90 Y ?-radiation versus placebo control for the treatment of in-stent restenosis
- Sigmund Silber, Jeffrey J. Popma, Mohan Suntharalingam, Alexandra J. Lansky, Richard R. Heuser, Burton Speiser, Paul S. Teirstein, Theodore Bass, William O'Neill, John Lasala, Mark Reisman, Samin K. Sharma, Richard E. Kuntz, Raoul Bonan, for the START Investigators
- Safety and accuracy of multidetector row computed tomography for early assessment of residual stenosis of the infarct-related artery and the number of diseased vessels after acute myocardial infarction
- Kuan-Rau Chiou, Ming-Ting Wu, Shih-Hung Hsiao, Guang-Yuan Mar, Huay-Ben Pan, Chien-Fang Yang, Chun-Peng Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?